日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Intensive Lowering of LDL Cholesterol Levels With Evolocumab in Autoimmune or Inflammatory Diseases: An Analysis of the FOURIER Trial

使用依洛尤单抗强化降低自身免疫性或炎症性疾病患者的低密度脂蛋白胆固醇水平:FOURIER试验分析

Zimerman, Andre; Kunzler, Ana Laura F; Weber, Brittany N; Ran, Xinhui; Murphy, Sabina A; Wang, Huei; Honarpour, Narimon; Keech, Anthony C; Sever, Peter S; Sabatine, Marc S; Giugliano, Robert P